Find Funding Opportunities

Find Funding Opportunities

Subscribe to Find Funding OpportunitiesRSS
Returning 1316 results

Notice of Change to Funds Available and Anticipated Number of Awards for RFA-MH-21-140, "BRAIN Initiative Cell Census Network (BICCN) Scalable Technologies and Tools for Brain Cell Census (R01 Clinical Trial Not Allowed)"

NOT
Tuesday, January 12, 2021
Monday, January 1, 2024
NOT-MH-21-155

Funding Opportunity Purpose

This notice increases the Funds Available and Anticipated Number of Awards for RFA-MH-21-140.

Notice of Cancellation of May 25, 2021 submission date for PAR-20-076 "Jointly Sponsored Ruth L. Kirschstein National Research Service Award Institutional Predoctoral Training Program in the Neurosciences (T32 Clinical Trial Not Allowed)

NOT
Monday, December 21, 2020
Monday, January 1, 2024
NOT-NS-21-018

Funding Opportunity Purpose

The purpose of this notice is to inform potential applications of a cancellation of the May 25, 2021 submission date for PAR-20-076 "Jointly Sponsored Ruth L. Kirschstein National Research Service Award Institutional Predoctoral Training Program in the Neurosciences (T32).

Notice of Change to Key Dates for PAR-18-304 "NIH SIREN Neurologic Clinical Trials (U01 Clinical Trial Required)"

NOT
Monday, December 21, 2020
Monday, January 1, 2024
NOT-NS-21-020

Funding Opportunity Purpose

The purpose of this notice is to inform applicants of a change to the Key Dates for PAR-18-304 "NIH SIREN Neurologic Clinical Trials (U01 Clinical Trial Required)". This funding opportunity announcement has been extended by one additional council round. The dates have been modified to add the following New Application Due Date: February 5, 2021, and Renewal, Resubmission, RevisionDate: March 5, 2021.

Notice of Clarification to Career Stages Supported for PAR-20-240 "NIH Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed)"

NOT
Thursday, December 17, 2020
Monday, January 1, 2024
NOT-NS-21-019

Funding Opportunity Purpose

The purpose of this notice is to inform applicants of a correction to the Career Stages Supported for PAR-20-240 "NIH Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed)". Section I of the Funding Opportunity has been modified to show that researchers from diverse backgrounds, including from groups underrepresented in the neuroscience scientific workforce at one of more of the following career levels: graduate, postdoctoral and/or junior faculty levels are eligible under this Funding Opportunity Announcement.

Notice of NINDS Participation in PAR-19-343 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Not Allowed)"

NOT
Tuesday, December 8, 2020
Monday, January 1, 2024
NOT-NS-21-015

Funding Opportunity Purpose

The purpose of this Notice is to inform potential applicants that the National Institute of Neurological Disorders and Stroke (NINDS) will participate in PAR-19-343, "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Not Allowed)." The first available "Application Due Date" is June 12, 2020. NINDS participation in the MOSAIC will replace the NINDS Advanced Postdoctoral Career Transition Award to Promote Diversity in Neuroscience Research (K22), the K22 program will expire on May 8, 2021.

Notice of Removal of Cost Matching Requirements for RFA-NS-21-010 "HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)"

NOT
Wednesday, November 25, 2020
Monday, January 1, 2024
NOT-NS-21-016

Funding Opportunity Purpose

The purpose of this notice is to inform potential applicants of a change to the Budget Justification for RFA-NS-21-010 "HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)".

Notice of NIH Participation in Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science

NOT
Tuesday, November 24, 2020
Monday, January 1, 2024
NOT-OD-21-011

Funding Opportunity Purpose

The purpose of this Notice is to announce that the NIH is collaborating with the National Science Foundation (NSF) on an interagency funding opportunity, Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science. The initiative supports innovative, high-risk/high-reward research with the promise of disruptive transformations in biomedical research. Proposals submitted must make fundamental contributions to two or more disciplines such as computer or information sciences, engineering, social, behavioral, biomedical, cognitive and/or economic sciences to improve fundamental understanding of biomedical and health related processes and address a key health problem.

Notice of Special Interest: Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp Clinical Trial Optional)

Notice of Special Interest
Tuesday, November 17, 2020
Friday, March 5, 2021
333
NOT-OD-21-020
Khara Ramos

Funding Opportunity Purpose

The NIH Office of Science Policy (OSP) within the Office of the Director (OD) announces the availability of administrative supplements to support 1) research on bioethical issues to develop or support the development of an evidence base that may inform future policy directions, and/or 2) certain efforts to develop or augment bioethics research capacity. Applicants may propose to supplement parent awards focused on bioethics or to add a component related to bioethics to a parent award in which bioethics was not the focus. Note that applications must be within the general scope of the parent award.

Notice of Intent to Publish a Funding Opportunity Announcement for Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33)

NOT
Monday, November 9, 2020
Monday, January 1, 2024
NOT-NS-21-008

Funding Opportunity Purpose

(Reissue of PAR-18-763) This funding opportunity announcement (FOA) encourages the development and validation of animal models and human/animal tissue ex vivo systems that recapitulate the phenotypic and physiologic characteristics of a defined neurological or neuromuscular disorder. The goal of this FOA is to promote a significant improvement in the translational relevance of animal models or ex vivo systems that will be utilized to facilitate the development of neurotherapeutics. Ideally, models proposed for this FOA would have the potential to provide feasible and meaningful assessments of efficacy following therapeutic intervention that would be applicable in both preclinical and clinical settings. This FOA is part of a suite of Innovation Grants to Nurture Initial Translational Efforts (IGNITE) Program focused on enabling the exploratory and early stages of drug discovery.

Notice of Intent to Publish a Funding Opportunity Announcement for Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)

NOT
Monday, November 9, 2020
Monday, January 1, 2024
NOT-NS-21-007

Funding Opportunity Purpose

(Reissue of PAR-18-762) This funding opportunity announcement (FOA) encourages research grant applications to develop in vitro and/or ex vivo assays and conduct iterative screening efforts to identify and characterize potential therapeutic agents for neurological disorders. This FOA is part of a suite of Innovation Grants to Nurture Initial Translational Efforts (IGNITE) to advance projects to the point where they can meet the entry criteria for the Blueprint Neurotherapeutics Network (BPN) or other translational programs.

Pages